Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer

被引：7
|
作者：
Zhu, Alec [1 ]
Garcia, Jorge Alberto [2 ]
Faltas, Bishoy [3 ]
Grivas, Petros [4 ]
Barata, Pedro [2 ]
Shoag, Jonathan E. [5 ]
机构：
[1] NewYork Presbyterian Hosp, Dept Urol, Weill Cornell Med, New York, NY USA
[2] Case Western Reserve Univ, Univ Hosp, Cleveland Med Ctr, Dept Med, Cleveland, OH USA
[3] NewYork Presbyterian Hosp, Div Hematol & Med Oncol, Dept Med, Weill Cornell Med, New York, NY USA
[4] Univ Washington Med, Div Med Oncol, Dept Med, Fred Hutchinson Canc Ctr, Seattle, WA USA
[5] Univ Hosp Cleveland Med Ctr, Case Western Reserve Univ, Dept Urol, Sch Med, Cleveland, OH USA
来源：
JAMA NETWORK OPEN | 2023年 / 6卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2023.7444
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cohort study uses published clinical trial data to assess long-term survival of patients with metastatic urothelial carcinoma who are treated with immune checkpoint inhibitors.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.
    Tural, Deniz
    Arslan, Cagatay
    Selcukbiricik, Fatih
    Olmez, Omer Fatih
    Akar, Emre
    Erman, Mustafa
    Urun, Yuksel
    Erdem, Dilek
    Kilickap, Saadettin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors
    Tural, Deniz
    Arslan, Cagatay
    Selcukbiricik, Fatih
    Olmez, Omer Fatih
    Erman, Mustafa
    Urun, Yuksel
    Erdem, Dilek
    Kilickap, Saadettin
    [J]. CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [3] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Iris Y. Sheng
    Shilpa Gupta
    Chandana A. Reddy
    Dana Angelini
    Pauline Funchain
    Tamara A. Sussman
    Joseph Sleiman
    Moshe C. Ornstein
    Keith McCrae
    Alok A. Khorana
    [J]. Targeted Oncology, 2022, 17 : 563 - 569
  • [4] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Sheng, Iris Y.
    Gupta, Shilpa
    Reddy, Chandana A.
    Angelini, Dana
    Funchain, Pauline
    Sussman, Tamara A.
    Sleiman, Joseph
    Ornstein, Moshe C.
    McCrae, Keith
    Khorana, Alok A.
    [J]. TARGETED ONCOLOGY, 2022, 17 (05) : 563 - 569
  • [5] The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors
    Lai-Kwon, J. E.
    Khoo, C.
    Lo, S.
    Milne, D.
    Mohamed, M.
    Raleigh, J.
    Smith, K.
    Lisy, K.
    Sandhu, S. K.
    Jefford, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] Long-term survival outcomes with immune checkpoint inhibitors (ICI) in metastatic uveal melanoma (MUM).
    Lee, Cha Len
    Walsh, Naomi
    Keane, Fergus
    Lynch, Emer
    Reddan, Tadhg
    Craig, Helen
    O'Meara, Aileen
    Smith, Deirdre
    O'Neill, Valerie
    Horgan, Noel
    Kennedy, Susan
    Gullo, Giuseppe
    Crown, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
    Nuzzo, Pier Vitale
    Pond, Gregory R.
    Abou Alaiwi, Sarah
    Nassar, Amin H.
    Flippot, Ronan
    Curran, Catherine
    Kilbridge, Kerry L.
    Wei, Xiao X.
    McGregor, Bradley A.
    Choueiri, Toni
    Harshman, Lauren C.
    Sonpavde, Guru
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [8] Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
    Shabto, Julie M.
    Martini, Dylan J.
    Liu, Yuan
    Ravindranathan, Deepak
    Brown, Jacqueline
    Hitron, Emilie E.
    Russler, Greta A.
    Caulfield, Sarah
    Kissick, Haydn
    Alemozaffar, Mehrdad
    Ogan, Kenneth
    Harris, Wayne B.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet A.
    [J]. CANCER MEDICINE, 2020, 9 (08): : 2752 - 2760
  • [9] Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?
    Dingemans, A-M C.
    Hendriks, L. E. L.
    [J]. LANCET RESPIRATORY MEDICINE, 2019, 7 (04): : 291 - 292
  • [10] Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit
    Peron, Julien
    Lambert, Alexandre
    Munier, Stephane
    Ozenne, Brice
    Giai, Joris
    Roy, Pascal
    Dalle, Stephane
    Machingura, Abigirl
    Maucort-Boulch, Delphine
    Buyse, Marc
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (11) : 1186 - 1191
12345